Safety of shortened infusion times for combined ipilimumab and nivolumab

ConclusionsShortened infusion times for combined ipilimumab and nivolumab treatment are safe, thereby facilitating a more efficient use of outpatient facilities and enhancing patient ’s convenience.

http://link.springer.com/10.1007/s00262-017-2075-y

Source: Cancer Immunology, Immunotherapy - October 7, 2017 Category: Cancer & Oncology Source Type: research